Isolated Glenohumeral Corticosteroid Injection Versus Concomitant Capsule Preserving Hydrodilatation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 5, 2013

Primary Completion Date

November 17, 2015

Study Completion Date

November 17, 2015

Conditions
Adhesive CapsulitisAdhesive Capsulitis of Shoulder
Interventions
PROCEDURE

Ultrasound-guided glenohumeral space isolated corticosteroid injection

Using a 21-gauge spinal needle, the predefined steroid solution was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.

PROCEDURE

Ultrasound-guided glenohumeral space concomitant hydrodilatation with corticosteroid injection

Using a 21-gauge spinal needle, the predefined steroid solution with additional 15 mL of normal saline was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.

DRUG

1mL of Triamcinolone (40mg/1mL) Injectable Solution

1mL of Triamcinolone 40mg/1mL solution was included in the injection/hydrodilatation regimen.

DRUG

4mL of Lidocaine 1% Solution Injectable Solution

4mL of 1% Lidocaine solution was included in the injection/hydrodilatation regimen.

DRUG

15mL of Normal Saline

15mL of 1% Lidocaine solution was included in the hydrodilatation regimen.

Trial Locations (1)

700-204

Chuncheon Sacred Heart Hospital, Chuncheon

All Listed Sponsors
lead

Chuncheon Sacred Heart Hospital

OTHER

NCT06493656 - Isolated Glenohumeral Corticosteroid Injection Versus Concomitant Capsule Preserving Hydrodilatation | Biotech Hunter | Biotech Hunter